Exploratory analysis for the evaluation of lopinavir/ritonavir-versus efavirenz-based HAART regimens in antiretroviral-naive HIV-positive patients: results from the Italian MASTER Cohort-Reference-Cited by-同舟云学术

Exploratory analysis for the evaluation of lopinavir/ritonavir-versus efavirenz-based HAART regimens in antiretroviral-naive HIV-positive patients: results from the Italian MASTER Cohort

Published:2005-05-25 Issue:1 Volume:56 Page:190-195
ISSN:1460-2091
Container-title:Journal of Antimicrobial Chemotherapy
language:en
Short-container-title:

Author:

Torti Carlo,Maggiolo Franco,Patroni Andrea,Suter Fredy,Ladisa Nicoletta,Paraninfo Giuseppe,Pierotti Piera,Orani Anna Maria,Minoli Lorenzo,Arici Claudio,Sighinolfi Laura,Tinelli Carmine,Carosi Giampiero

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Pharmacology (medical),Pharmacology,Microbiology (medical)

Link

http://academic.oup.com/jac/article-pdf/56/1/190/2084923/dki172.pdf

Reference16 articles.

1. Yeni PG, Hammer SM, Hirsch MS et al. Treatment for adult HIV infection. 2004 recommendations of the International AIDS Society-USA Panel. JAMA2004; 292: 251–65.

2. Panel on Clinical Practices for Treatment of HIV Infection. Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents. Updated 29 October 2004. http://AIDSInfo.nih.gov. (1 December 2004, date last accessed).

3. Walmsey S, Bernstein B, King M et al. Lopinavir-ritonavir versus nelfinavir for the initial treatment of HIV infection. N Engl J Med2002; 346: 2039–46.

4. Robbins GK, De Gruttola V, Shaker RW et al. Comparison of sequential three drug regimens as initial therapy for HIV infection. N Engl J Med2003; 349: 2304–15.

5. Carosi G, Castelli F, Suter F et al. Antiviral potency of HAART regimens and clinical success are not strictly couplet in real life conditions: evidence from the MASTER-1 study. HIV Clin Trials2001; 2: 399–407.

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Treatment outcomes of initial differential antiretroviral regimens among HIV patients in Southwest China: comparison from an observational cohort study;BMJ Open;2019-03

2. Moving forward with treatment options for HIV-infected children;Expert Opinion on Pharmacotherapy;2017-09-18

3. Cohort Profile: Standardized Management of Antiretroviral Therapy Cohort (MASTER Cohort);International Journal of Epidemiology;2015-10-07

4. Use of efavirenz or atazanavir/ritonavir is associated with better clinical outcomes of HAART compared to other protease inhibitors: routine evidence from the Italian MASTER Cohort;Clinical Microbiology and Infection;2015-04

5. Immunological Function Restoration with Lopinavir/Ritonavir Versus Efavirenz Containing Regimens in HIV-Infected Patients: A Randomized Clinical Trial;AIDS Research and Human Retroviruses;2014-05